Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 22, 2010 - Issue 10
255
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Malondialdehyde and superoxide dismutase correlate with FEV1 in patients with COPD associated with wood smoke exposure and tobacco smoking

, , , , , & show all
Pages 868-874 | Received 13 Nov 2009, Accepted 02 May 2010, Published online: 28 Jun 2010

References

  • Agacdiken A, Basyigit I, Ozden M, Yildiz F, Ural D, Maral H, Boyaci H, Ilgazli A, Komsuoglu B. 2004. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology 9:38–42.
  • Barregard L, Sällsten G, Andersson L, Almstrand AC, Gustafson P, Andersson M, Olin AC. 2008. Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup Environ Med 65:319–324.
  • Boots AW, Haenen GR, Bast A. 2003. Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:14s–27s.
  • Brauer M, Bartlett K, Regalado-Pineda J, Pérez-Padilla R. 1996. Assessment of particulate concentrations from domestic biomass combustion in rural Mexico. Environ Sci Tech 30:104–109.
  • Bruce N, Pérez-Padilla R, Albalak R. 2002. The health effects of indoor air pollution exposure in developing countries. Geneva: World Health Organization: 9.
  • Carlberg I, Mannervik B. 1975. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475–5480.
  • Celli BR, MacNee W; ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932–946.
  • Ceylan E, Kocyigit A, Gencer M, Aksoy N, Selek S. 2006. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med 100:1270–1276.
  • Chung KF, Adcock IM. 2008. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 31:1334–1356.
  • Danielsen PH, Bräuner EV, Barregard L, Sällsten G, Wallin M, Olinski R, Rozalski R, Møller P, Loft S. 2008. Oxidatively damaged DNA and its repair after experimental exposure to wood smoke in healthy humans. Mutat Res 642:37–42.
  • Diaz JV, Koff J, Gotway MB, Nishimura S, Balmes JR. 2006. Case report: a case of wood-smoke-related pulmonary disease. Environ Health Perspect 114:759–762.
  • Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. 2005. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 60:293–300.
  • Gérard-Monnier D, Erdelmeier I, Régnard K, Moze-Henry N, Yadan JC, Chaudière J. 1998. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 11:1176–1183.
  • Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139.
  • Hankinson JL, Odencrantz JR, Fedan KB. 1999. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–187.
  • Hanta I, Kocabas A, Canacankatan N, Kuleci S, Seydaoglu G. 2006. Oxidant-antioxidant balance in patients with COPD. Lung 184:51–55.
  • Isik B, Isik RS, Akyildiz L, Topçu F. 2005. Does biomass exposure affect serum MDA levels in women? Inhal Toxicol 17:695–697.
  • Joppa P, Petrásová D, Stancák B, Dorková Z, Tkácová R. 2007. Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 119:428–434.
  • Kluchová Z, Petrásová D, Joppa P, Dorková Z, Tkácová R. 2007. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 56:51–56.
  • Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. 2006. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 27:397–412.
  • MacNee W. 2005. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:50–60.
  • Menezes AM, Victora CG, Perez-Padilla R; PLATINO Team. 2004. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 4:15.
  • Morandi MT, Ward TJ; Risk Assessment Workgroup. 2010. Wood smoke risk assessment: defining the questions. Inhal Toxicol 22:94–98.
  • Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR. 2007. Woodsmoke health effects: a review. Inhal Toxicol 19:67–106.
  • Pedraza-Chaverrí J, Maldonado PD, Medina-Campos ON, Olivares-Corichi IM, Granados-Silvestre MA, Hernández-Pando R, Ibarra-Rubio ME. 2000. Garlic ameliorates gentamicin nephrotoxicity: relation to antioxidant enzymes. Free Radic Biol Med 29:602–611.
  • Pérez-Padilla R, Regalado J, Vedal S, Paré P, Chapela R, Sansores R, Selman M. 1996. Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study. Am J Respir Crit Care Med 154:701–706.
  • Pérez-Padilla JR, Regalado-Pineda J, Vázquez-García JC. 2001. [Reproducibility of spirometry in Mexican workers and international reference values]. Salud Publica Mex 43:113–121.
  • Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555.
  • Rahman I. 2005a. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 43:167–188.
  • Rahman I. 2005b. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 4:175–200.
  • Ramírez-Venegas A, Sansores RH, Pérez-Padilla R, Regalado J, Velázquez A, Sánchez C, Mayar ME. 2006. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 173:393–397.
  • Ramlogan R. 1997. Environment and human health: a threat to all Environmental Management and Health. 8:51–66.
  • Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. 2008. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359:1543–1554.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.